| RPRX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RPRX shares outstanding history going back to 6/16/2020:
Also see: RPRX Market Cap History RPRX YTD Return |
RPRX Shares Outstanding History — Royalty Pharma Share Count Over Time
As of 5/1/2026 Royalty Pharma has 443.27 million RPRX shares outstanding. Investors often track the RPRX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RPRX share count trends over time, with 24 historical shares outstanding datapoints presented, dating back to 6/16/2020.
| RPRX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
RPRX Historical Shares Outstanding: +4.07% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| RPRX Stock Price Chart |
| About Royalty Pharma plc |
| Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. Co. collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex's Trikafta, GSK's Trelegy, Roche's Evrysdi, Johnson & Johnson's Tremfya, Biogen's Tysabri and Spinraza, AbbVie and Johnson & Johnson's Imbruvica, Astellas and Pfizer's Xtandi, Novartis' Promacta, Pfizer's Nurtec ODT and Gilead's Trodelvy, and 14 development-stage product candidates. We show 24 historical shares outstanding datapoints in our coverage of RPRX's shares outstanding history. Understanding the changing numbers of RPRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RPRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RPRX by allowing them to research RPRX shares outstanding history as well as any other stock in our coverage universe. |
| RPRX Current Stock Quote |
Quotes delayed 20 minutes  Free RPRX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| RPRX Share Performance |
| Shares Outstanding Peers |
| Royalty Pharma (RPRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RSLS Shares Outstanding History RTIX Shares Outstanding History RTRX Shares Outstanding History RTTR Shares Outstanding History RUBY Shares Outstanding History RVMD Shares Outstanding History RVNC Shares Outstanding History RVPH Shares Outstanding History RVTY Shares Outstanding History RXDX Shares Outstanding History More Healthcare companies » |
RPRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
